Thermo Fisher Scientific (TMO) Short-term Investments (2009 - 2026)

Thermo Fisher Scientific has reported Short-term Investments for 11 years, with the latest figure at $2.0 million in Q1 2026.

• Short-term Investments for Q1 2026 came in at $2.0 million, down 99.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (down 99.89% YoY), and the FY2025 annual result was $253.0 million, down 83.79% from the prior year.
• Short-term Investments fell to $2.0 million in Q1 2026, from $253.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $2.0 billion in Q3 2024 and troughed at $2.0 million in Q1 2026.
• A 4-year average of $1.3 billion and a median of $1.7 billion in 2024 frame the typical range for Short-term Investments.
• The widest annual swing landed in 2024, when Short-term Investments jumped 51933.33%; it then sank 99.89% in 2026.
• A 4-year view of Short-term Investments shows it stood at $3.0 million in 2023, then jumped by 51933.33% to $1.6 billion in 2024, then plunged by 83.79% to $253.0 million in 2025, then slumped by 99.21% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $2.0 million in Q1 2026, $253.0 million in Q4 2025, and $1.6 billion in Q3 2025.